Oseltamivir vs Tofacitinib
Oseltamivir vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Oseltamivir and Tofacitinib.
Mechanism of Action
Oseltamivir: Neuraminidase inhibitor preventing viral release from host cells.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Oseltamivir β 6-10 hours; Tofacitinib β 3.2 hours.
Chemical Properties
Molecular Formula: Oseltamivir β C16H28N2O4; Tofacitinib β C16H20N6O.
Molecular Weight: Oseltamivir β 312.4050 g/mol; Tofacitinib β 312.3700 g/mol.
Type: Oseltamivir β Small molecule; Tofacitinib β Small molecule.